NEURODYSLEPTIC THERAPY. CLINICAL TRIALS IN CHRONIC SCHIZOPHRENIA WITH A NEW BUTYROPHENONE DERIVATIVE R-2498.
D035843:Biomedical Research; D004358:Drug Therapy; D012559:Schizophrenia; D014116:Toxicology; D014149:Tranquilizing Agents; D014272:Trifluperidol
D014149:Tranquilizing Agents; D014272:Trifluperidol
CLINICAL RESEARCH; DRUG THERAPY; SCHIZOPHRENIA; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIFLUPERIDOL